GENE ONLINE|News &
Opinion
Blog

Psoriasis
Moonlake Announces $250 Million Public Offering
2023-06-29
Amgen Out-Licenses Two Therapies to Fosun Pharma to Expand Presence in China
2022-06-28
Dermavant Sciences’ Psoriasis Drug Promises in Phase 3 Trials
2021-02-20
Bristol Myers Squibb Registers Another Trial Win for its Psoriasis Med
2021-02-03
Bristol Myers Squibb’s Deucravacitinib Impresses in Phase 3 Psoriasis Trial
2020-11-04
Cosentyx Bags EU Approval for First-Line Treatment of Pediatric Psoriasis
2020-08-05
LATEST
Innovative Cellular Mapping of BRCA-Related Breast Cancer Findings Reveals Novel Therapeutic Targets
2024-03-29
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top